Early Access — free while we kick the tires
EdgarHawk

Paula Green

SVP of Human Resources

Officer

Latest: SVP of Human Resources selling · June 2026

2 filings analyzed · 1 company · Latest 2026-06-17

Companies

Company Buys Sells Direction
Twist Bioscience Corp TWST 0 4 Net selling

Activity

June 2026
2026-06-17 Twist Bioscience Corp TWST
high
Sell
26,137 shares
$2,134,488
Significance 6/10

SVP HR Paula Green sold 26,137 shares at $81.62–$82.17 for $2.1M, retaining 120.7K shares

Paula Green, SVP of Human Resources, executed two separate sales totaling 26,137 shares for $2,134,487.77 on 2026-06-15, reducing her stake by 17.8% to 120,705 remaining shares. The sales at a blended average price of $81.67 occurred while TWST trades near its 52-week high (current price $82.87, -6.3% from peak), following a sharp 66.4% rally over the prior 30 days. Green's prior sell at this ticker on 2026-02-17 produced a negative 90-day return of -5.0%, consistent with her cross-ticker well-timed rate of 100.00% on prior sells. The company remains unprofitable (net income -$44.0M on revenue of $110.7M) despite 20.3% annual revenue growth, which provides limited fundamental support for sustained momentum following the recent gain.

February 2026
2026-02-19 Twist Bioscience Corp TWST
medium
Sell
39,404 shares
$2,064,770
Significance 6/10

SVP HR Paula Green sold 39,404 shares of TWST at $52.40; retains 126,041 shares after 23.8% reduction in holdings.

Paula Green, SVP of Human Resources, sold 39,404 shares for $2,064,769.60 on 2026-02-17, representing a 23.8% reduction in her prior holdings to 126,041 shares. The sale occurred near Twist Bioscience's 52-week high of $54.92, within 2.52 points of peak valuation. The broader context is material: the company generated $103.7M in quarterly revenue with annual growth of 20.3%, but reported a full-year net loss of $30.5M and remains unprofitable. This sale by a human resources executive—a non-operational role without direct business visibility—provides limited insight into management's assessment of product or commercial trajectory. The transaction's significance lies in its size and timing relative to market peaks rather than any strategic signal about company fundamentals.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access